Pike Survives Tennessee Execution Attempt After Two Doses

Tennessee attempted to execute Christa Pike on September 30, 2026, but she survived after personnel administered two doses of pentobarbital. Months earlier, her lawyers had warned a court that a blood disorder and difficulty accessing her veins could complicate a lethal injection. The reports do not establish that those medical risks caused the procedure to fail. In a complaint filed in January, Pike’s lawyers said she had MPN-related thrombocytosis, a condition involving an elevated platelet count associated with myeloproliferative neoplasm, a disorder affecting blood-cell production in the bone marrow. They argued that the condition could increase her risk of pulmonary edema, a potentially serious buildup of fluid in the lungs, during an execution by injection. The lawyers also described a history of difficult blood draws and needle insertion. They said medical staff had used a butterfly needle to collect Pike’s blood because of concerns about accessing her veins and causing pain. Their filing argued that her condition and Tennessee’s execution procedures created an unacceptable risk of suffering. It also objected to changes in the state’s protocol that, according to the...